NSEAnalysts/Institutional Investor Meet/Con. Call Updates3 Aug 2026 · 3 Aug 2026, 06:38 pm
Analysts/Institutional Investor Meet/Con. Call Updates
Marksans Pharma Limited · MARKSANS
✦ AI SummaryResults
Marksans Pharma Limited has scheduled a conference call on August 13, 2026, to discuss its unaudited financial results for the quarter ended June 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Marksans Pharma Limited has informed the Exchange about schedule for Q1FY27 Earnings Conference Call
Attachments (1)
📄pdf
Download →
MARKSANS_03082026183731_SeIntimation.pdf
View document text
August 03, 2026
BSE Limited National Stock Exchange of India Limited
Corporate Relation Department Listing Department
Phiroze Jeejeebhoi Towers, Exchange Plaza, C-1, Block-G,
Dalal Street, Bandra-Kurla Complex,
Mumbai – 400001. Bandra (East), Mumbai – 400051.
Scrip Code: 524404 Symbol: MARKSANS
Subject: Intimation of schedule for Q1FY27 Earnings Conference Call
Dear Sir/Madam,
Pursuant to Regulation 30 read with Para A of Part A of Schedule III of SEBI (Listing
Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the
Company has scheduled a conference call for analysts and investors on Thursday, August 13,
2026 at 04:30 PM (IST) to discuss the Unaudited Financial Results (Standalone and
Consolidated) of the Company for the quarter ended June 30, 2026.
The details and schedule with respect to the conference call is enclosed herewith.
The presentation along with the audio recording of the call and the transcript will be hosted on
the Company’s website at https://www.marksanspharma.com/earnings-call-transcripts.html
We request you to take the aforesaid on your records.
Thanking you.
Yours faithfully,
For Marksans Pharma Limited
Harshavardhan Panigrahi
Company Secretary
Encl: As below
Marksans Pharma Ltd.
11th Floor, "GRANDEUR", Opp. Gundecha Symphony, Veera Desai Extension Road, Oshiwara, Andheri
(W), Mumbai - 400 053 Tel.: +91 22 4001 2000
E-mail: companysecretary@marksanspharma.com
www.marksanspharma.com
Marksans Pharma Ltd
Q1FY27 Earnings Call
Thursday, 13 August 2026 at 16:30 hrs (IST)
CIN: L24110MH1992PLC066364
DAM Capital Advisors Ltd invites you to
Marksans Pharma Ltd’s post results conference call
Marksans Pharma Ltd’s Management Speakers
Mr. Mark Saldanha – Founder, Chairman and Managing Director
Mr. Jitendra Sharma – Chief Financial Officer
Call Leaders
Nitin Agarwal – Analyst, DAM Capital Advisors Ltd
Dial-in Details
Universal access: +91 22 6280 1384, +91 22 7115 8285
(accessible from all networks and countries)
Diamond passcode link: click here
International dial-in
Hong Kong Singapore UK USA
19:00 (HKT) 19:00 (SGT) 12:00 PM (BST) 07:00 (EDT)
Toll free 800964448 8001012045 08081011573 18667462133
*Please dial-in at least 5-10 minutes prior to the schedule to get connected to the call in time
For further information please contact
Nitin Agarwal / Payal Shah
DAM Capital Advisors Limited
: +91 22 4202 2568 / 2638
nitin.a@damcapital.in / payal@damcapital.in